e.l.f. Beauty price target raised to $150 from $115 at Jefferies

Published 12/06/2025, 11:04
e.l.f. Beauty price target raised to $150 from $115 at Jefferies

Jefferies raised its price target on e.l.f. Beauty (NYSE: NYSE:ELF) to $150 from $115 on Monday, while maintaining a Buy rating on the cosmetics company’s stock. The company, currently trading at $124.52, has demonstrated impressive growth with a 28.28% revenue increase over the last twelve months, though InvestingPro analysis suggests the stock is trading above its Fair Value.

The research firm cited e.l.f.’s acquisition of skincare brand Rhode as a key factor in the increased valuation, noting several growth catalysts including Sephora distribution, new product launches, and improving web traffic.

Jefferies highlighted that Rhode currently ranks as the number one beauty brand globally in terms of earned media value growth, with less than 1% of its social content being sponsored.

The firm estimates that the Rhode transaction could be low double-digit percentage accretive to e.l.f. Beauty’s earnings per share in fiscal year 2026, with projected Rhode revenues of $240 million for that period.

The new $150 price target represents approximately 21 times Jefferies’ fiscal year 2027 enterprise value to EBITDA estimate for e.l.f. Beauty.

In other recent news, e.l.f. Beauty has been the focus of several analyst updates following its announcement of fourth-quarter results that exceeded expectations. Raymond (NSE:RYMD) James raised its price target for e.l.f. Beauty to $130, maintaining a Strong Buy rating, citing the company’s growth strategies and international expansion plans. Similarly, TD Cowen also increased its price target to $130, highlighting the strategic acquisition of the skincare brand Rhode for $1 billion as a key growth driver. Truist Securities followed suit, significantly raising its price target to $125 from $75, reflecting increased confidence in e.l.f. Beauty’s sales and EBITDA projections for fiscal years 2026 and 2027.

Deutsche Bank (ETR:DBKGn) adjusted its price target to $96, maintaining a Hold rating, while acknowledging the positive initial impact of the Rhode acquisition but noting uncertainties in the operating environment. Morgan Stanley (NYSE:MS) raised its price target to $105, with an Equalweight rating, pointing to favorable outcomes related to tariffs and a beneficial court ruling. The acquisition of Rhode is expected to expand e.l.f. Beauty’s presence in the skincare market, complementing its existing product offerings. Despite some uncertainties, analysts remain optimistic about e.l.f. Beauty’s potential to capture market share in both the mass market and prestige sectors. These developments underscore the company’s strategic efforts to navigate a competitive beauty market while leveraging its recent successes.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.